103 related articles for article (PubMed ID: 1300481)
21. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease.
Sriram K; Matheson JM; Benkovic SA; Miller DB; Luster MI; O'Callaghan JP
FASEB J; 2002 Sep; 16(11):1474-6. PubMed ID: 12205053
[TBL] [Abstract][Full Text] [Related]
22. Significant up-regulation of nestin protein in the neostriatum of MPTP-treated mice. Are the striatal astrocytes regionally activated after systemic MPTP administration?
Chen LW; Wei LC; Qiu Y; Liu HL; Rao ZR; Ju G; Chan YS
Brain Res; 2002 Jan; 925(1):9-17. PubMed ID: 11755896
[TBL] [Abstract][Full Text] [Related]
23. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Araki T; Muramatsu Y; Tanaka K; Matsubara M; Imai Y
Neurosci Lett; 2001 Oct; 312(1):50-4. PubMed ID: 11578843
[TBL] [Abstract][Full Text] [Related]
24. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
Kato H; Kurosaki R; Oki C; Araki T
Brain Res; 2004 Dec; 1030(1):66-73. PubMed ID: 15567338
[TBL] [Abstract][Full Text] [Related]
25. Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice.
Takagi S; Hayakawa N; Kimoto H; Kato H; Araki T
J Neural Transm (Vienna); 2007; 114(12):1553-7. PubMed ID: 17676428
[TBL] [Abstract][Full Text] [Related]
26. Indirubins deplete striatal monoamines in the Intact and MPTP-treated mouse brain and block kainate-induced striatal astrogliosis.
Magiatis P; Polychronopoulos P; Skaltsounis AL; Lozach O; Meijer L; Miller DB; O'Callaghan JP
Neurotoxicol Teratol; 2010; 32(2):212-9. PubMed ID: 20034560
[TBL] [Abstract][Full Text] [Related]
27. Astrocyte-specific transcriptome analysis using the ALDH1L1 bacTRAP mouse reveals novel biomarkers of astrogliosis in response to neurotoxicity.
Michalovicz LT; Kelly KA; Vashishtha S; Ben-Hamo R; Efroni S; Miller JV; Locker AR; Sullivan K; Broderick G; Miller DB; O'Callaghan JP
J Neurochem; 2019 Aug; 150(4):420-440. PubMed ID: 31222732
[TBL] [Abstract][Full Text] [Related]
28. Manganese does not alter the severe neurotoxicity of MPTP.
Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y
Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923
[TBL] [Abstract][Full Text] [Related]
29. FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells.
Otto D; Unsicker K
Glia; 1994 May; 11(1):47-56. PubMed ID: 8070894
[TBL] [Abstract][Full Text] [Related]
30. Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency.
Bagga P; Crescenzi R; Krishnamoorthy G; Verma G; Nanga RP; Reddy D; Greenberg J; Detre JA; Hariharan H; Reddy R
J Neurochem; 2016 Nov; 139(3):432-439. PubMed ID: 27529288
[TBL] [Abstract][Full Text] [Related]
31. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha.
Sriram K; Matheson JM; Benkovic SA; Miller DB; Luster MI; O'Callaghan JP
FASEB J; 2006 Apr; 20(6):670-82. PubMed ID: 16581975
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive fluorescent imaging of gliosis in transgenic mice for profiling developmental neurotoxicity.
Ho G; Zhang C; Zhuo L
Toxicol Appl Pharmacol; 2007 May; 221(1):76-85. PubMed ID: 17350065
[TBL] [Abstract][Full Text] [Related]
33. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
34. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
Watanabe H; Muramatsu Y; Kurosaki R; Michimata M; Matsubara M; Imai Y; Araki T
Eur Neuropsychopharmacol; 2004 Mar; 14(2):93-104. PubMed ID: 15013024
[TBL] [Abstract][Full Text] [Related]
36. Polyamine metabolism in reversible cerebral ischemia: effect of alpha-difluoromethylornithine.
Paschen W; Röhn G; Meese CO; Djuricic B; Schmidt-Kastner R
Brain Res; 1988 Jun; 453(1-2):9-16. PubMed ID: 3135921
[TBL] [Abstract][Full Text] [Related]
37. Cerebral alterations in a MPTP-mouse model of Parkinson's disease--an immunocytochemical study.
Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
J Neural Transm (Vienna); 2003 Oct; 110(10):1129-44. PubMed ID: 14523625
[TBL] [Abstract][Full Text] [Related]
38. A role for transforming growth factor alpha as an inducer of astrogliosis.
Rabchevsky AG; Weinitz JM; Coulpier M; Fages C; Tinel M; Junier MP
J Neurosci; 1998 Dec; 18(24):10541-52. PubMed ID: 9852591
[TBL] [Abstract][Full Text] [Related]
39. Effects of progesterone administered after MPTP on dopaminergic neurons of male mice.
Litim N; Morissette M; Di Paolo T
Neuropharmacology; 2017 May; 117():209-218. PubMed ID: 28192111
[TBL] [Abstract][Full Text] [Related]
40. Effect of manganese exposure on MPTP neurotoxicities.
Baek SY; Lee MJ; Jung HS; Kim HJ; Lee CR; Yoo C; Lee JH; Lee H; Yoon CS; Kim YH; Park J; Kim JW; Jeon BS; Kim Y
Neurotoxicology; 2003 Aug; 24(4-5):657-65. PubMed ID: 12900079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]